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Abstract
Objective: At present, only the number of metastatic lymph nodes (LNs+) is used for the pN category of AJCC TNM system
for colon cancer. Recently, the ratio of metastatic to examined lymph nodes (LNR) has been reported to represent powerful
independent predictive capacity in colon cancer. We sought to propose a novel category (nLN) which intergrades LNR and
LNs+ into the AJCC staging system for colon cancer.
Design: 34476 patients from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) dataset with
stage III colon cancer were reviewed. Harrell’s C statistic was used to evaluate the predictive capacity. The Cox proportional
hazards model was used to construct a novel category.
Results: The LNR category had more predictive capacity than the pN category in whole groups of patients (Harrell’s C index:
0.6194 vs 0.6113, p=0.003). Subgroup analysis showed that the LNR category was not better than pN category in predictive
capacity if the number of lymph nodes examined was more than 13. We also found that there was significant survival
heterogeneity among different pN categories at the same LNR category (P,0.001). The Harrell’s C index for our nLN
category which intergrades LNR and LNs+ was 0.6228, which was significant higher than that of the pN category (Harrell’s C
index: 0.6113, P,0.001) or LNR category (Harrell’s C index: 0.6194, P=0.005), respectively.
Conclusion: To evaluate the prognosis of colon cancer, our nLN category which intergrades LNR with LNs+ is more accurate
than the pN category or LNR category, respectively.
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Introduction
Colon cancer is one of the most common malignancies [1]. The
International American Joint Committee on Cancer (AJCC) TNM
staging system is currently regarded as the strongest prognostic
parameter for patients with colon cancer [2]. Lymph node
metastasis is one of the most important prognostic factors.
Determination of the optimal approach to quantifying lymph
node status in colon cancer will ensure accurate patient staging,
allowing appropriate adjuvant treatment planning and calculation
of long-term prognosis.
At present, only the number of metastatic lymph nodes (LNs+)i s
used for the pN category of AJCC TNM system for colon cancer.
This has been criticized as an oversimplification because the
number of metastatic lymph nodes is influenced by the total
number of examined lymph nodes (eLNs) and may increase the
probability of stage migration [3,4]. As we know, the eLNs
pathologically has been demonstrated to affect both staging
accuracy and oncological outcomes in node-positive patients [5].
The optimal eLNs for reliable prognostic stratification is less clear
until now. According to the guidelines from the AJCC, a
minimum of 10–14 lymph nodes must be examined and
histopathologically assessed in the tumor specimen to adequately
evaluate lymph node status [6]. The college of American
Pathologists recommends a minimum of 12 lymph nodes to be
examined for colon cancer [7]. Some researchers also proposed
that the resection of at least 13, 14 or 15 nodes was associated with
prolonged survival in colon cancer for the categories examined [8–
10]. Unfortunately, surgeons and pathologists do not generally
succeed in meeting minimal nodal staging. For those cases without
an adequate number of retrieved lymph nodes, the pN category
may be not accurate enough.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35021Over the past few years, the ratio of metastatic to examined
lymph nodes (LNR) has been studied widely. Nearly all
researchers demonstrated that the LNR is an independent
prognostic factor that is highly related to the survival of patients
with colon cancer and it has been recommend that the LNR
should be applied in prognostic assessment [11–18]. However, it is
still unclear whether the LNR has more prognostic validity than
the AJCC pN category [18,19].
This study is based on a dataset supported by the Surveillance,
Epidemiology, and End Results (SEER) cancer registry with 34476
cases that suffered colon cancer. We found that the LNR category
had more predictive capacity than the pN category in the whole
groups of patients. However, if the eLNs was more than 13, the
LNR category was not better than pN category in predictive
capacity. Additionally, there was significant survival heterogeneity
among different pN categories at the same LNR category. Finally,
we proposed a new category approach that intergraded LNR and
LNs+ into the AJCC staging system for colon cancer.
Materials and Methods
Data
The dataset we used is the National Cancer Institute’s
Surveillance, Epidemiology, and End Results (SEER) dataset,
1973–2007. SEER collects data on cancer cases from various
locations and sources throughout the United States. Data
collection began in 1973 with a limited amount of registries and
continues to expand to include even more areas and demographics
today. The number of records in the SEER research dataset is up
to 6127828 including 5564451 malignant cases. Among these
patients, more than 500000 patients suffered from colorectal
cancer. Patients with stage III colon cancer diagnosed from 1992
through 2003 were selected for analysis. The primary study
endpoint was cancer-specific survival.
Patients were excluded from this study if they had: 1) a prior
non-colon cancer or colon cancer other than adenocarcinoma or
mucinous adenocarcinomas 2) underwent preoperative radiation,
because it was reported that the total number of retrieved lymph
nodes may decrease after preoperative chemoradiation [20]; 3)
incomplete pathological data entries; or 4) died during the
immediate postoperative period (within one month).
After using these exclusion strategies, a dataset consisting of
34476 records was constructed and the following data were
recorded: age, gender, race, depth of invasion (determined by
SEER’s ‘‘extent of disease’’), histologic grade, number of lymph
nodes retrieved, and number of metastatic lymph nodes. Then, the
LNR was defined as the ratio of LNs+ divided by the eLNs. To
avoid some biases such as the complex category may be over
optimized in the comparison of predictive capacity between
different categories, models constructed by the categories were
found in a training set of data, and then their predictive capacity
determined in a test set of data, independent of the training set
[21]. Therefore, of the 34476 cases, half were randomly selected
for training and the remaining 17238 were used for testing.
Ethics statement
We have got permission to access the research data file in SEER
program.
Statistical Analysis
Continuous data were presented as the mean 6 standard
deviation (SD). Cancer-specific survival was analyzed by Kaplan-
Meier survival curves, and comparisons were made by the log-
rank test. Multivariate analysis was performed using Cox
proportional hazards model.
We evaluated the predictive capacity of categories by
considering measures of discrimination. Discrimination refers
to the ability to distinguish between high-risk and low-risk
patients, and was quantified using the Harrell’s C statistic,
Nagelkerke R
2, Bayesian Information Criterion (BIC), and time
dependent cumulative area under the curve (AUC) [22–26]. A
model with perfect predictive capacity (sensitivity and specificity
of 100%) would have a Harrell’s C index of 1.00; a category with
higher Harrell’s C index was considered more accurate in
predictive capacity. The Nagelkerke R
2 index was also used to
score the different categories. R
2 represents the proportion of
variation explained by covariates in regression models. R
2 is
close to 1 for a perfectly predictive model, and close to 0 for a
category that does not discriminate between short and long
survival times. The BIC was used to assess the overall prognostic
performance of different classification systems via bootstrap-
resampling analysis. A smaller BIC value indicates a more
desirable model for predicting outcome. The AUC was a
common tool for the purpose of assessing the predictive power of
a continuous variable for a binary outcome and cumulative AUC
which was an extension of it to censored survival data was used
to evaluate the accuracy of categories in survival prediction at
different time.
The cut-off values for sub-groups of LNR were determined
using Harrell’s C statistic calculated from the training dataset
[8,22]. To study whether the predictive capacity of the LNR
category is better than pN category with set standards for the
minimal eLNs, a series of tests were performed. There were 20
tests run using a standard for the minimal eLNs from 2 to 21. In
each test, a Harrell’s C statistic was determined to test the
predictive capacity of LNR categories and pN categories.
Comparison of the survival rate among different pN categories
stratified by LNR categories was run to analyze the heterogeneity.
A log-rank test was run to compare the survival rate among
different pN categories in each LNR category.
The novel category (nLN) which combines the pN category
with the LNR category is based on the hazard ratio calculated
by Cox proportional hazards model. The formula of Cox
proportional hazards model is: H(t)=H0(t)~exp(b1x1z
b2x2zb3x3z:::zbkxk),w h e r ex1…xk are a collection of
predictor variables, LNs+ and LNR in this study, b1…bk are
regression coefficients determined by a least squares approach,
and the H(t)=H0(t) is called the hazard ratio. Moreover, we
grouped the calculated hazard ratio four risk levels and formed
our nLN category and the optimal cut-off values for the nLN
category were also determined using Harrell’s C statistic
calculated from the training dataset. And then, we compared
the predictive capacities of this nLN category with single LNR
category and single pN category. Moreover, to test whether the
nLN category will have more predictive values irrespective of
the eLNs, comparison of the survival rate between patients with
,12 eLNs and $12 eLNs stratified by all three categories was
run.
All the statistical analyses and graphics were performed with the
PASW Statistics 18.0 software (SPSS, Inc., Somers, NY, USA),
SigmaPlot 12.0 (Systat Software Inc), R version 2.14.0 (The R
Foundation for Statistical Computing), Splus 8.0 (Insightful
Corporation, Seattle, WA, USA) and STATA MP ver.10
(StataCorp LP, College Station, TX) statistical software. For all
analysis, P,0.05 was considered significant.
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According to the 7th edition of the UICC/AJCC TNM staging
system, based on the number of positive lymph nodes, patients
with different pN categories were divided into: N1a, 34.3%
(11826/34476); N1b, 33.8% (11665/34476); N2a, 19.6% (6747/
34476); and N2b, 12.3% (4238/34476). Survival differences
among the groups were statistically significant (P,0.001; Table 1).
Based on optimal cut-off values determined using Harrell’s C
statistic respectively, patients were divided into the following LNR
subgroups: LNR1=an LNR,0.13; LNR2=an LNR between
0.13 and 0.24; LNR3=an LNR between 0.24 and 0.51; and
LNR4=an LNR.0.51. The 5-year survival rate decreased
significantly with increasing LNR categories (P,0.001; Table 1).
Moreover, in univariate analysis, age, race, histologic grade and
pT categories were also identified as significantly correlated with
prognosis (Table 1). In the multivariate analysis, all clinicopath-
ological factors that were significantly correlated with prognosis in
univariate analysis were considered. Age, race, histologic grade,
pT categories, pN categories, and LNR categories were confirmed
to be independent prognostic factors (Table 2). Using Harrell’s C
statistic to test the predictive capacity of the category in all
patients, the LNR categories was significantly better than the pN
Table 1. Univariate analysis of the prognostic factors for
patients.
n
a 5-YSR
b(%) P*
Sex 0.794
Male 16193 60.4
Female 18283 60.7
Age ,0.001
#60 8991 67.8
60–75 13745 63.1
.75 11740 51.8
Race ,0.001
White 27659 60.6
Black 3559 57.7
Other 3258 65.3
Histologic grade ,0.001
Well 1789 67.7
Median 23112 63.7
Poor 9268 52.2
Undifferentiated 307 49.8
pT category ,0.001
T1 855 86.4
T2 2722 80.8
T3 24328 62.4
T4a 3871 50.4
T4b 2700 30.4
pN category ,0.001
N1a 11826 72.3
N1b 11665 63.6
N2a 6747 51.3
N2b 4238 35.1
LNR
c category ,0.001
LNR1 10492 74.2
LNR2 7448 66.2
LNR3 10261 56.6
LNR4 6275 37.7
nLN
d category ,0.001
nLN1 7747 75.5
nLN2 12395 67.0
nLN3 9157 53.6
nLN4 5177 35.1
n
a: Number of patients.
5-YSR
b: 5-year accumulative survival rate.
LNR
c: ratio of metastatic to examine lymph nodes.
nLN
d: the novel category proposed in this study.
*P values were made by log-rank test.
doi:10.1371/journal.pone.0035021.t001
Table 2. Multivariate Analysis (Cox Proportional Hazard
Model) of Prognostic Factors.
HR
a 95% CI
b P
Age 1.022 1.020–1.023 ,0.001
Race ,0.001
White* 1
Black 1.258 1.192–1.328
Other 0.873 0.822–0.927
Histologic grade ,0.001
Well* 1
Median 1.100 1.013–1.195
Poor 1.316 1.208–1.433
Undifferentiated 1.442 1.205–1.726
pT category ,0.001
T1* 1
T2 1.287 1.063–1.558
T3 2.538 2.133–3.021
T4a 3.393 2.838–4.057
T4b 6.386 5.338–7.640
pN category ,0.001
N1a* 1
N1b 1.045 0.988–1.106
N2a 1.192 1.112–1.277
N2b 1.479 1.368–1.599
LNR
c category ,0.001
LNR1* 1
LNR2 1.146 1.060–1.238
LNR3 1.333 1.219–1.457
LNR4 1.637 1.459–1.836
nLN
d category ,0.001
nLN1 1
nLN2 1.170 1.071–1.279
nLN3 1.312 1.164–1.480
nLN4 1.646 1.425–1.902
HR
a: hazard ratio.
CI
b: confidence interval.
LNR
c: ratio of metastatic to examine lymph nodes.
nLN
d: the novel category proposed in this study.
*: reference category.
doi:10.1371/journal.pone.0035021.t002
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p=0.003).
As seen in Figure 1, following the elevation of standard for the
number of minimal eLNs increasing from 2 to 13, the Harrell’s C
index for LNR category was always higher than that for pN
category. The difference between the predictive capacities of the
LNR categories and pN categories was significant when the
number of minimal eLNs is from 2 to 6 (P,0.05) and the
difference lost statistical significance when the number of minimal
eLNs was from 7 to 13 (P.0.05). However, as the minimal eLNs
increased from 14 to 21, the Harrell’s C index for pN category was
slightly higher than that for LNR category, but the difference
between them was not significant(p.0.05).
Using log-rank test, comparison of the survival rates among
different LNR categories in different pN categories revealed that
there were significant prognostic differences among patients in
different pN categories for any LNR category (P,0.001; Fig. 2A,
2B, 2C, 2D). Furthermore, as seen in Figure 2E which reflects the
prognostic hazard ratio based on a Cox proportional hazards
model with LNR and LNs+ as covariates, at the same LNR level,
following the elevation of LNs+, the prognostic hazard ratio
increased. That also means there was significant survival
heterogeneity among different pN categories at the same LNR
category.
A Cox proportional hazards regression with both LNR and
LNs+ as covariates was run to calculate the prognostic hazard
ratio (HR). After determining the parameters b, the formula was:
HR~exp(1:1875|LNRz0:0484|LNsz). Then, we grouped
the patients into four risk levels according to HR and formed the
nLN category: nLN1=an HR,1.21; nLN2=an HR between
1.21 and 1.62; nLN3=an HR between 1.62 and 2.72; and
nLN4=an HR.2.72 (Fig. 2F). Patients with different nLN
categories were divided into: nLN1, 34.3% (7747/34476); nLN2,
36.0% (12395/34476); nLN3, 26.6% (9157/34476); and nLN4,
15.0% (5177/34476). Survival differences among the groups were
statistically significant (P,0.001; Table 1). In the multivariate
analysis, the nLN category was significantly correlated with
prognosis.
Figures 3A, 3B and 3C display the survival curves based on
three different category approaches: pN categories, LNR catego-
ries and our nLN categories. We compared the Nagelkerke R
2 and
Harrell’s C among the three categories. As a result, the nLN
category had the highest Nagelkerke R
2 (pN categories: 0.063;
LNR categories: 0.065; nLN categories: 0.072; Table 3). In
addition, comparison of Harrell’s C statistics and BIC also
revealed that our nLN categories had a better predictive capacity
than both pN categories and LNR categories (p,0.05; Table 3).
Moreover, the results of comparison of cumulative AUC
demonstrated that the nLN categories had a higher accuracy in
survival prediction than both pN categories and LNR categories at
all post-operation time points (Fig. 4).
Comparison of the survival rate between patients with $12
eLNs and ,12 eLNs stratified by all three categories revealed that
the heterogeneities of prognosis between patients with ,12 eLNs
and $12 eLNs at nLN categories was the lowest among three
categories. In four pN categories there were significant survival
differences between patients with ,12 eLNs and $12 eLNs (5-
year accumulative survival rates: 69.0% vs. 76.4% at N1a,
p,0.001; 59.9% vs. 67.9% at N1b, p,0.001; 44.3% vs. 57.4%
at N2a, p,0.001; 29.2% vs. 36.8% in N2b, p,0.001; Fig. 5A).
Although the heterogeneities of prognosis between patients with
,12 eLNs and $12 eLNs at LNR categories were lower than that
of pN categories, there were significant survival heterogeneities in
four LNR categories (5-year accumulative survival rates: 72.5% vs.
74.7% at LNR1, p=0.017; 69.0% vs. 64.0% at LNR2, p,0.001;
59.1% vs. 52.3% at LNR3, p,0.001; 41.8% vs. 28.7% at LNR4,
p,0.001; Fig. 5B). Conversely, there were no significant survival
heterogeneities between patients with ,12 eLNs and $12 eLNs at
nLN2 and nLN3 (5-year accumulative survival rates: 67.4% vs.
66.6% at nLN2, p=0.422; 54.3% vs. 52.7% at nLN3, p=0.268).
There were survival differences in nLN1 and nLN4 (5-year
accumulative survival rates: 72.9% vs. 76.3% at nLN1, p=0.001;
39.2% vs. 29.3% at nLN4, p,0.001; Fig. 5C).
Discussion
Over the past few years, LNR has been studied widely in the
prognostic analysis of colon cancer. Nearly all researchers
demonstrated that the LNR is an independent prognostic factor.
However, it is still unclear whether the LNR category has more
prognostic validity than the AJCC pN category [18,19]. In our
study, we compared the predictive capacity of the LNR category
with that of pN based on the SEER dataset. We found that the
LNR category was significantly better than the pN category in
predictive value in whole groups of patients (Harrell’s C index:
0.6194 vs 0.6113, respectively, p=0.003). This result was similar
to previous studies [14,15,17,26,27].
However, there is still debate on whether the LNR has more
prognostic validity than the AJCC pN category if the eLNs is
enough. Priolli et al. analyzed the prognostic value of the LNR in
patients with no less than 12 eLNs and multivariate analysis
Figure 1. The results of Harrell’s C statistical analysis, which reflects the predictive capacity of pN categories and LNR categories
using different standards for the minimal number of lymph nodes examined. The p value reflects the significance of comparison between
pN categories and LNR categories using different standards for the minimal number of lymph nodes examined.
doi:10.1371/journal.pone.0035021.g001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35021Figure 2. Differences in cause-specific survival in patients of four LNR categories when classified by AJCC pN categories. (a) Survival
curves for patients of LNR1; (b) Survival curves for patients of LNR2; (c) Survival curves for patients of LNR3; (d) Survival curves for patients of LNR4; (e)
Mesh plots reflect the predictive hazard ratio based on a Cox proportional hazards model with LNR and LNs+ as covariates. (f) Mesh plots with the
green, yellow, and red planes which subgroup the hazard ratios into four risk levels (hazard ratio: ,1.21, 1.21–1.62, 1.62–1.72 and .1.72).
doi:10.1371/journal.pone.0035021.g002
Figure 3. Differences in cause-specific survival in patients of colon cancer when classified by three categories. (a) Survival curves for
patients classified by AJCC pN categories; (b) Survival curves for patients classified by LNR categories; (c) Survival curves for patients classified by the
novel categories (nLN).
doi:10.1371/journal.pone.0035021.g003
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independent prognostic factors. Furthermore, lymph node in-
volvement obtained a higher ‘score’ than the LNR [16]. Recently,
based on the SEER dataset, Chen et al. compared the prognostic
values of the LNR categories with that of the pN categories in
patients with no less than 12 eLNs. Multivariate analysis showed
that both LNR and lymph node involvement were independent
prognostic factors. They proposed that the LNR categories had
better prognostic value than the pN categories for the reason that
the LNR categories had a higher hazard ratio than the pN
categories [28]. In this study, we found that when the minimal
eLNs was no less than 14, the predictive capacity of the pN
categories was even higher than the LNR categories, although the
difference is not significant statistically. That meant that LNR
category was not superior to pN category in the predictive
captivity all the time. Maybe this result could be affected by the
cut-off value of the LNR categories, while the optimal cut-off value
for LNRs has not received consensus [29] and the cut-off values
used in this study were searched by statistic method to ensure the
efficiency.
Moreover, it was verified that there was significant survival
heterogeneity among different pN categories at the same LNR
category. Using log-rank test, comparison of the survival rates
among different LNR categories in different pN categories
revealed that there were significant prognostic differences among
patients in different pN categories for any LNR category
(P,0.001; Fig. 2A, 2B, 2C, 2D). Therefore, it is not scientific
enough if the pN category is simply replaced by LNR category.
The result of Cox proportional hazards model with LNR and
LNs+ as covariates also supported this opinion (Fig. 2E).
Nevertheless, the prognostic value of LNR could not be ignored.
Maybe a category which integrated the LNR with LNs+ is
considerable.
In light of these considerations, a Cox proportional hazards
regression with both LNR and LNs+ as covariates was run to
calculate the prognostic hazard ratio (HR). After calculation of the
parameters, the formula:
HR~exp(1:1875|LNRz0:0484|LNsz) was obtained. Both
the LNR and LNs+ were referred by this formula and the large
dataset used in this study make sure that the parameters 1.1875
and 0.0484 were accurate. And then, we divided calculated HR
into four risk levels and formed our new category (nLN):
nLN1=an HR,1.21; nLN2=an HR between 1.21 and 1.62;
nLN3=an HR between 1.62 and 2.72; and nLN4=an HR.2.72.
Survival differences among the groups were statistically
significant (P,0.001). Furthermore, using three statistical meth-
ods; i.e., Nagelkerke R
2, Harrell’s C and BIC, we verified the
effectiveness of the nLN category and compared it with the LNR
categories and pN categories, respectively. We found that the nLN
category had higher predictive capacity than the other two
categories (Table 3). Moreover, based on comparison of
cumulative AUC, we found that the nLN categories had a higher
accuracy in survival prediction than both pN categories and LNR
categories at all post-operation time points (Fig. 4). Furthermore,
compared with pN and LNR categories, the nLN category had
more value in reduction of the heterogeneity of prognosis caused
by insufficient eLNs. In the present study, we found significant
heterogeneities of prognosis between patients with ,12 eLNs and
$12 eLNs at all four pN and LNR categories (Fig. 5A, 5B).
Conversely, there was no heterogeneities of prognosis between
patients with ,12 eLNs and $12 eLNs at nLN2 and nLN3 of the
nLN category (Fig. 5C). To some degree, the nLN category can be
used to counterbalance incomplete nodal assessment for patho-
logical evaluation and increase the accuracy of prognostic
predication irrespective of the eLNs. These findings indicated
that nLN categories were suitable for predicting the prognosis of
patients with colon cancer. And then, based on the nLN category,
the patients may obtain some clinical benefit from accurate
prediction of long-term prognosis and appropriate adjuvant
treatment planning.
Figure 4. Comparison of cumulative area under the curve
analysis among three categories in survival prediction at
different time.
doi:10.1371/journal.pone.0035021.g004
Table 3. Compare Nagelkerke R
2, Harrell’s C and Bayesian Information Criterion among three categories.
Nagelkerke R
2 Harrell’s C BIC
a
Coefficient 95% CI
b P
c Coefficient P
c
pN category 0.063 0.6113 0.6046–0.6180 ,0.001 22175.87 ,0.001
LNR
d category 0.065 0.6194 0.6127–0.6260 0.005 22404.12 ,0.001
nLN
e category 0.072 0.6228 0.6162–0.6294 22581.11
BIC
a: Bayesian Information Criterion.
CI
b: confidence interval.
P
c: comparing the predictive power of survival models with novel category.
LNR
d: ratio of metastatic to examine lymph nodes.
nLN
e: the novel category proposed in this study.
doi:10.1371/journal.pone.0035021.t003
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exploratory study based on SEER data. Clinical and pathologic
patient information can be heterogeneous since SEER collects
information from 12 population-based cancer registries. On the
other hand, data on adjuvant therapy is limited to information
on radiation therapy only and it was reported that the total
number of retrieved lymph nodes may decrease after preoper-
ative chemotherapy [20]. Also, there is a lack of information on
other factors that are related to the total number of retrieved
lymph nodes, such as BMI index [28]. This makes some
subgroup analysis impossible. Further, external validation by
using other sources of data with sufficient pathological
information is needed.
We conclude that, to evaluate the prognosis of colon cancer, our
nLN category which intergrades LNR with LNs+ is more accurate
than the pN category or LNR category, respectively.
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